NCT/Study#

NCT04214067 /

NRG-GY020-JTCC

NRG Oncology, Protocol: NRG-GY020, PI: Dr. McNamara, Title: A Phase III Randomized Trial of Radiation +/- Mk-3475 (Pembrolizumab) for ACTIVEly Diagnosed Early Stage High Intermediate Risk Mismatch Repair Deficient (Dmmr) Endometrioid Endometrial Cancer

NRG Oncology, Protocol: NRG-GY020, PI: Dr. McNamara, Title: A Phase III Randomized Trial of Radiation +/- Mk-3475 (Pembrolizumab) for ACTIVEly Diagnosed Early Stage High Intermediate Risk Mismatch Repair Deficient (Dmmr) Endometrioid Endometrial Cancer

DISEASE GROUP:
Gynecologic
current phase:
Phase III
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information: